IQV · IQVIA Holdings Inc.
$173.262026-05-17Sector: Healthcare; Industry: Medical - Diagnostics & Research; Sub-Industry: Life Sciences Tools & Services
Intrinsic Value Range Comparison · Mulya.ai
Base · active
$162
-6.3% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($143 · $341) Analysts Range ($210 · $258) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $13.9B | — | 10.0% | 14.4% | $1.2B | −$157MM | $1.0B | 9.7% | — | 7.1% | $16.7B | $5.62 | — |
| 2022.Q4 | $14.4B | 3.9% | 12.5% | 19.2% | $1.5B | −$963MM | $490MM | 10.0% | — | 8.6% | $17.2B | $6.35 | — |
| 2023.Q4 | $15.0B | 4.0% | 13.2% | 6.9% | $1.8B | −$793MM | $1.0B | 10.1% | — | 10.4% | $18.3B | $7.90 | — |
| 2024.Q4 | $15.4B | 2.8% | 14.3% | 18.0% | $1.8B | −$40MM | $1.8B | 10.3% | — | 9.9% | $18.2B | $7.99 | — |
| 2025.Q4 | $16.3B | 5.9% | 14.0% | 15.6% | $1.9B | −$427MM | $1.5B | 10.5% | — | 10.0% | $20.3B | $7.91 | 13.0 |
| italics below = DCF projection · 10yr Rev CAGR: 5.4% |
| 2026.Q4 | $17.2B | +5.7% | 14.1% | 16.1% | $2.0B | −$314MM | $1.7B | 10.3% | $1.6B | 10.0% | $20.6B | $11.90 | 14.6 |
| 2027.Q4 | $18.2B | +5.8% | 14.8% | 16.5% | $2.2B | −$364MM | $1.9B | 10.2% | $1.6B | 10.8% | $21.0B | $13.08 | 13.2 |
| 2028.Q4 | $19.3B | +6.0% | 15.6% | 16.9% | $2.5B | −$433MM | $2.1B | 10.0% | $1.6B | 11.8% | $21.4B | $14.60 | 11.9 |
| 2029.Q4 | $20.6B | +6.4% | 16.3% | 17.4% | $2.8B | −$543MM | $2.2B | 9.8% | $1.5B | 12.8% | $22.0B | $16.14 | 10.7 |
| 2030.Q4 | $21.8B | +5.8% | 16.3% | 17.8% | $2.9B | −$583MM | $2.3B | 9.6% | $1.5B | 13.1% | $22.5B | $16.99 | 10.2 |
|
| Term. Yr+ | $28.6B | 4.1% | 19.6% | 20.0% | $4.5B | −$1.4B | $3.1B | 8.6% | $27.4B | 13.1% | — | — | — |
Active scenario IV: $162 (-6.3% vs market)